Skip to main content
Premium Trial:

Request an Annual Quote

Medical Solutions to Buy Geneservice for $7.6M

NEW YORK (GenomeWeb News) — Medical Solutions plans to buy Geneservice for ₤3.9 million ($7.6 million), Medical Solutions said in a statement on Thursday.
Geneservice, a 2005 spinout of the UK’s Medical Research Council, provides genomics services, such as qPCR, to academic and corporate clients.
Medical Solutions said it is looking to expand its diagnostic and prognostic tests, and said it believes qPCR will be “the favored technology” for many diagnostics in five to 10 years.
Medical Solutions said it stands to benefit through “direct access to the technologies and expertise which Geneservice provides,” and Geneservice will “gain clinical expertise and credibility in the healthcare and pharmaceutical communities.”
The company said it is still working out the details on moving Geneservice from Cambridge to Nottingham, UK. Geneservice has a staff of 35 at its Cambridge facility.
Medical Solutions said Geneservice’s revenue for the 11-month period ended Feb. 28 was ₤2.4 million, an increase of 35 percent year-over-year.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.